Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma
- PMID: 9352689
- DOI: 10.1046/j.1464-410x.1997.00408.x
Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma
Abstract
Objective: To determine the immunophenotype of tumour-infiltrating lymphocytes (TIL) and peripheral blood lymphocytes (PBL) isolated from patients with renal cell carcinoma (RCC) and to analyse the correlations between the quantity of analysed cell subsets and the progression of the disease.
Patients and methods: PBL and TIL samples were obtained from 23 patients with RCC at different stages of disease. The immunophenotype of PBL and TIL was measured, and the TNM stage, tumour size, cellular type, histological grade, lymphocytic infiltration and performance status assessed.
Results: The predominant mononuclear cells infiltrating the tumour, in all patients, were T lymphocytes (CD3+ median 66.9%, CD8+ median 34.6%, CD4+ median 26.7%). The cells possessing gamma/delta type T cell receptor accounted for a small fraction of the T cells in PBL and TIL (median 5.6% and 3.7%). Tumour-infiltrating T lymphocytes had a significantly higher percentage of cells expressing human leucocyte antigen (HLA) DR (median 30.9%) and CD25 (median 6.2%) antigens than the equivalent populations in peripheral blood from the same patient group (P < 0.001). The degree of T cell activation appeared to negatively correlate with the tumour stage (K = -0.3, P = 0.04). The percentage of natural killer (NK) cells among TIL (median 15.4%) did not reflect the value in PBL. The percentage of B cells in TIL was slightly lower than in PBL and accounted for 5.0% of cells. There was no relationship between the degree of lymphocytic infiltration and either tumour stage or grade but there appeared to be a positive correlation between the intensity of lymphocytic infiltration and the percentage of CD4+ cells in TIL (K = 0.5, P = 0.001). Moreover, the composition of TIL depended on tumour grade, which positively correlated with the percentage of CD8+ cells (K = 0.4, P = 0.005) and negatively with the percentage of NK cells (K = -0.5, P = 0.005). There was an inverse correlation with the percentage of gamma/delta T cells in PBL and the TIL concentration (K = -0.3, P < 0.05).
Conclusions: The TIL immunophenotype is different from PBL and is influenced by the histological grade of the tumour. The activation of TIL and its relationship with tumour progression suggests that they might be sensitized and activated by tumour cells.
Similar articles
-
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.Clin Exp Immunol. 1997 Sep;109(3):501-9. doi: 10.1046/j.1365-2249.1997.4771375.x. Clin Exp Immunol. 1997. PMID: 9328129 Free PMC article.
-
Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.Acta Medica (Hradec Kralove). 2007;50(3):207-12. Acta Medica (Hradec Kralove). 2007. PMID: 18254275
-
[Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].Vnitr Lek. 2008 Feb;54(2):139-45. Vnitr Lek. 2008. PMID: 23687704 Czech.
-
Human liver-associated lymphocytes: an overview.J Gastroenterol Hepatol. 1995;10 Suppl 1:S43-6. doi: 10.1111/j.1440-1746.1995.tb01796.x. J Gastroenterol Hepatol. 1995. PMID: 8589341 Review.
-
Signaling defects in T lymphocytes of patients with malignancy.Cancer Immunol Immunother. 1999 Oct;48(7):346-52. doi: 10.1007/s002620050585. Cancer Immunol Immunother. 1999. PMID: 10501846 Free PMC article. Review.
Cited by
-
The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma.Indian J Urol. 2021 Jan-Mar;37(1):13-19. doi: 10.4103/iju.IJU_293_20. Epub 2021 Jan 1. Indian J Urol. 2021. PMID: 33850351 Free PMC article. Review.
-
Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.Oncoimmunology. 2017 Feb 6;6(3):e1284723. doi: 10.1080/2162402X.2017.1284723. eCollection 2017. Oncoimmunology. 2017. PMID: 28405516 Free PMC article.
-
Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.Hum Vaccin Immunother. 2015;11(7):1612-20. doi: 10.1080/21645515.2015.1035849. Hum Vaccin Immunother. 2015. PMID: 25996049 Free PMC article.
-
Specific von Hippel-Lindau protein expression of clear cell renal cell carcinoma with "immunogenic" features.Pathol Oncol Res. 2001;7(1):42-5. doi: 10.1007/BF03032604. Pathol Oncol Res. 2001. PMID: 11349220
-
Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.J Mol Med (Berl). 2009 Jun;87(6):595-612. doi: 10.1007/s00109-009-0455-2. Epub 2009 Mar 7. J Mol Med (Berl). 2009. PMID: 19271159 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials